InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.56
(
-0.17%
)
Bitcoin
64,996.91
(
0.05%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JJM760

Send PM Follow Ignore
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

JJM760

Re: biomaven0 post# 119571

Saturday, 05/07/2011 9:34:23 PM

Saturday, May 07, 2011 9:34:23 PM

Post# of 252255
Biomaven thanks for the great summary. I might be naive, but I have been wondering for a while why it has taken so long for Ariad to get the 113 trial started. Is it a financing issue, or is this a standard timeline for this type of drug? Would a large pharma have been able to push it through any quicker?

Also, I would think that with all of the developments for Rida and Pona sitting right in front of us, very little value has been assigned to such a young 113 at the current pps.

I might have to re-think my timeline for my position.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up